TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ardea Biosciences, Inc. (NASDAQ:RDEA) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Merger with AstraZeneca

  • If you who purchased shares of Ardea Biosciences, Inc. (NASDAQ:RDEA) prior to April 23, 2012 and currently hold any of those NASDAQ:RDEA shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

April 23, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in NASDAQ:RDEA shares concerning whether the offer by AstraZeneca to merger with Ardea Biosciences, Inc..at $32.00 per share and the takeover process are unfair to investors in Ardea Biosciences, Inc. (NASDAQ:RDEA) was announced. The investigations by law firms concern whether certain officers and dir...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: